■■ Pharmaceutical Manufacturer Prescription Assistance Programs: Are They Worth It? Providing medical carefor the uninsured population is agrowing concern. Approximately 45 million people in this countryhave no health insurance and the percentage of uninsured continues to grow. 1 Nearly 18% (8 million) of the uninsured arechildren while 1i n5a re adults aged 25 to 64 years. 1 In the face of this important social problem, the uninsured may forego health care services due to access issues, and in the end, utilize morecostly medical services due to untreated diseases. 2 It has been estimated that everyy ear,a sm any as 18,000 unnecessaryd eaths were caused by lack of health insurance. 3 In addition to the effect on quality of life, this issue has am ajor financial impact on the public health system. The Institute of Medicine estimated that the annual lost economic value of being uninsured in the United States is between $65 billion to $130 billion. 3 Escalating drug expenditures and reduced insurance coverage in the United States compounds the problem with access to prescription drugs. Pharmaceutical manufacturers offer prescription assistance programs (PAPs) to make certain brand-name prescription drugs available to low-income patients who aren ot eligible for public assistance programs and arew ithout private insurance. It was hoped that PAPs would have afavorable effect on health outcomes such as hospitalization rates and emergency department visits through improved medication access and adherence. 4, 5 PAPs have evolved to become as afety net for millions of needy Americans who aren ot eligible for comprehensive assistance programs and unable to affordtheir medications. Much evidence justifies the benefits of establishing aP AP to assist indigent patients in obtaining their needed medications. [6] [7] [8] [9] [10] [11] [12] Since 2006, am ajority of manufacturers have streamlined their PAPs to require1a pplication per year with the exception of Novo Nordisk, Forest, Sanofi-aventis, Sankyo, and Biovail. The development of a" universal" application process would greatly benefit patients and health careproviders by reducing personnel time required to complete individual applications tailored to specific manufacturers. Even if the PAPf orm is simplified in a moreu niversal format, our experience suggests that most patients will encounter difficulties completing the application on their own since the application requires an accurate interpretation of prescriptions to transcribe specific information such as drug name, strength, direction, quantity,duration, and number of authorized refills. Drug manufacturers frequently change their eligibility criteria and the list of drugs available in PAPs, making it difficult for indigent patients to stay abreast of the program changes. Additionally,m any underserved patients may be challenged with limited health literacy, 13 and some suffer from deteriorating health or cognitive status that prevents them from completing the applicationw ithout assistance.T herefore, it is critical for health carep roviders to help these patients through the enrollment process to ensurethat they have access to their required prescription drugs.
The increased need for PAPs makes the question of their operational cost important for administrators of medical clinics considering implementing such ap rogram. In their time and motion study reported in ar ecent issue of JMCP, Clay et al. attempted to capturethe overall cost of aP AP incurred by afree health clinic in Kansas City. 14 The results showed the estimated annual cost of providing PAPs ervice at the clinic was $81,835 at an average expense per patient ranging from $10.42 for a medication with 1a nnual application up to $46.30 for manufacturers requiring 4applications per year.The PAPenrollment process is time-and labor-intensive; therefore, personnel costs accounted for the highest component of the annual PAPexpenditure. Clay et al. used the wage of am edical assistant with an hourly rate of $12.21 plus benefits ($4.23) as the basis of the personnel cost. 14 This study establishes abenchmark for administrators who areconsidering the establishment of an onsite PAP at amedical facility similar in size and natureofthe population served at the Kansas City Free Health Clinic. Additionally,t his information is valuable for budget development while seeking funding or donations to establish or maintain aP AP.
Acomparison with aP AP in another medical clinic provides insight into the considerations made by Clay et al. 14 As the only Federally Qualified Health Center located in the Greater Lafayette, Indiana area, Tippecanoe Community Health Clinic (TCHC) provides coordinated primaryhealth caretomorethan 9,000 uninsured county residents annually who have limited access to health caredue to lack of financial resources or health caree xpense reimbursement. Moret han half of the clinic' s patients receive Medicaid assistance,a nd 40% areu ninsured. Furthermore, approximately 67% of apatient' sincome falls below the 100% federal poverty level. As the pharmacotherapist at TCHC, one of the authors provides comprehensive clinical pharmacy services through consultations with providers, PAP clerks, patients, and other allied health careprofessionals.
The PAPa tT CHC began in 1999 with 1p art-time nurse working 10 to15 hours per week and has expanded to its current staffing level of 1.8 full-time clerks with support from doctor of pharmacy candidates. The medical director and nursing supervisor provide managerial oversight of the PAP, and pharmacy consultation is accessible onsite. In 2005, TCHC processed 5,671 PAPa pplications (2,652 new and 3,019 renewals) contributing moret han $1.7 million in acquisition costs for the medications received. The PAPoffice resides within TCHC and offers both scheduled and walk-in services. Clinic patients are referred to PAPb yt heir providers or other patient advocates (e.g., pharmacist, specialists, dietician, and nurses). If an uninsured patient is unable to affordl ow-cost drug regimens (e.g., discounted generics through the 340B program or $4 local pharmacy generic drugs), individual prescriptions written per specific manufacturer guidelines areg iven to patients to bring to the PAPoffice to determine enrollment eligibility and process the application. Some differences exist between the PAPs at the Kansas City Free Health Clinic and TCHC. Due to the high volume of patient enrollments at TCHC, RxAssist Plus Patient and Medication Tracking Software 15 was installed to streamline the application process and reduce personnel time. To offset clinic expenses and encourage patient accountability,a$3processing fee for each application is required. All patients arer equired to pay,with the exception of homeless patients, for whom the fee is waived. If patients cannot affordthe processing fee, the application is placed on hold until they can affordit, or other sources areidentified to assist with the fee.
Individual credit checks arenot preformed at TCHC because manufacturers do not requirethis as part of the supporting documents. At TCHC, all new applications aresubmitted via either fax or mail, with the latter method producing slightly longer processing times but yielding mored ependability.T he original PAPa pplications aren ever destroyed, and only 1c opy of the application is kept on record. Although some manufacturers accept online orders, the majority of refill renewals arecommunicated through atoll-free telephone number.The personnel time required to renew an application is significantly less than the time needed to process anew application. However,Clay et al. 14 did not address the costs of renewing applications.
The monetaryi mputation estimated by Clay et al. may not have adequately captured the entirecost necessarytooperate a PAP. 14 First, the authors only accounted for the direct costs (e.g., personnel, supplies, application submission fees), required to process an application and dispense medications. Indirect costs such as utilities, office space, furnishings and equipment, as well as storage weren ot included in their final calculation. The overhead expenses may also include salarycosts of providers and other patient advocates since they,too, have an active role in ensuring proper functioning of the PAP. In addition, if clinics wish to utilize the computerized application method, the cost of necessarys oftwarea nd associated expenses should be considered in the budget calculation.
Second, the authors' personnel cost estimate was based solely on the salaryofmedical assistants, who have relatively low payroll expenses, and excluded costs for any managerial oversight or pharmacy involvement. Providing PAPwith the goal of improving patient outcomes requires ateam effort from avariety of patient advocates. One also needs to be mindful that the tasks required for PAPsubmissions and deliveryare typical of the functions of ap harmacist, particularly the ability to accurately interpret a prescription, dispense the medication, and deliver appropriate patient education. Without patient education, the full benefit of PAPmay not be evident because alack of patient education may contribute to medication errors and can negatively affect patients' health outcomes. Inclusion of ac linical pharmacist to support PAPi sv ital to its effectiveness given the specialized training pharmacists receive. Roles of aclinical pharmacist supporting PAPa dministration by am edical group or clinic may include but aren ot limited to: (a) making accessible and effective recommendations for therapeutic interchange; (b) serving as aliaison between the patient, other health careprofessionals, and the program; (c) dispensing sample medications while patients await PAPcoverage; (d) providing coordination of care; (e) providing patient counseling; (f) overseeing other support stafftoverify prescriptions; and (g) maintaining an updated formulary.
If inclusion of ap harmacist is not av iable option for the medical clinic, the time and resources needed to educate nonpharmacy personnel on methods to ensurem edication safety should be accounted for as well as the potential for staff turnover.A lternatively,p harmacy technicians, social workers, or other support staffworking under the supervision of apharmacist may be an effective and less costly choice to administer the program. Pharmacist-coordinated PAPp rograms in various settings have demonstrated net cost-savings to justify the higher pharmacy personnel costs. [6] [7] 11, 16 Third, medication deliverym ay take 2t o6w eeks, so other means to bridge with an accessible and affordable therapeutically equivalent alternative may be necessaryw hile waiting. This is ap otential area for medication errors since patients are at risk of duplicating drug therapies if they do not receive proper counseling to discontinue the bridge medication. Furthermore, if dose adjustment is needed during this period, ap atient may incorrectly administer the medication ordered at the previous dose without appropriate education.
Fourth, Clay et al. apparently did not measuret he time required for providers to review patient charts to ensuret hat appropriate medication doses ared ispensed. Additionally,s taff to provide coordination of careisneeded to avoid potential missteps and overlap that can affect the effectiveness of the PAP. For example, the drug manufacturer only allows one shipping address but medications in aP AP could be ordered independently by a specialist that does not practice in the same location as the primary carep rovider.I fap atient has an established PAPt hrough the primaryc arep rovider,a ll medications from that manufacturer will be deliveredt ot he patient' sp rimaryc arec linic. Hence, coordination of careb etween specialists and the primaryc are provider becomes essential for proper patient monitoring which makes outsourcing PAPaless attractive option.
Calculating the true cost to deliver PAPservices is important to the implementation, maintenance, and improvement of these programs. However,while financial considerations play asignificant role, other factors such as patient needs and outcomes are essential for consideration. Despite the necessarye xpenses involved in administering PAP, the net financial and human benefit generated from PAPf or patients and health care providers can be enormous. 17 Examples of cost-savings from the establishment of PAPs have been demonstrated in ar enal transplant clinic (a minimum of $4 was returned to the institution for $1 spent in the pharmacist' stime). 6 Additionally,aPAP at amedical center clinic resulted in cost savings of $237,985 over 6months, yielding abenefit-to-cost ratio of 2.2:1. 16 Nykamp and Ruggles reported that maintaining adherence to needed medications improves caref or underserved patients and leads to decreased health caree xpenditures. 18 This financial information can be useful to help obtain funding or calculate cost-sharing strategies necessarytooffset the administrative expenses.
Without PAPs, it will be nearly impossible for an onprofit clinic serving al arge underserved population to financially affordt he high cost of medications through the discounted 340B drug-pricing program. Nevertheless, underserved patients will not be able to affordthe sliding scale fee associated with the brand medications, and the uncompensated cost from medication expenditures will eventually be absorbed by the clinic, resulting in further debt. The last option would be to deny patients the medications they need that will, in turn, increase the overall health careexpenditurethrough hospitalizations and nursing home admissions, and emergency services. 19 Numerous patients at TCHC have affirmed, "If it werenot for PAP, Iwould not take my medications." Therefore, medical facilities that serve al arge indigent population will benefit from investing in personnel who can assist patients with PAP. The benefits of PAP likely outweigh the overall costs. Futures tudies evaluating the impact of PAPo np atients' health outcomes (economic as well as humanistic and clinical) for the entireh ealth system are needed to further confirm the benefits of the PAPfor uninsured patients.
